Sunday - November 16, 2025

Acute Coronary Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight

Acute Coronary Syndrome Competitive Landscape Acute Coronary Syndrome companies include Janssen Research & Development, DalCor Pharmaceuticals, Hyloris Pharmaceuticals, and others. (Albany, USA) DelveInsight’s “Acute Coronary Syndrome – Pipeline Insight, 2025” highlights over 5+ active clinical assets targeting diverse mechanisms in … Continue reading

Prostate Cancer Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight

Prostate Cancer Competitive Landscape Prostate cancer companies are Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra Pharmaceuticals, Bristol-Myers Squibb, MacroGenics, Syntrix Pharmaceuticals, Zenith Epigenetics, Xencor, Bristol Myers Squibb, Merus, Phosplatin Therapeutics, Laekna Therapeutics, Tavanta … Continue reading